One of our strong areas of expertise we look forward to sharing with you. We have the capabilities to custom develop and validate GLP-compliant methods:

• Qualitative and quantitative ELISA assays for detection of test substances or innovative therapeutic agents in formats such as direct, sandwich, bridge, competitive.
• Flow cytometry assays for:
  • Immunophenotyping of lymphocytes and other blood cells
  • Specific cell surface or intracellular marker combinations for the diagnosis and prognosis of hematopoetic cancers
  • Detection of peripheral CECs
• Immunohistochemical methods for the detection and quantification of protein expressions (intracellular or cell surface markers)
• Immunoblotting, immunophenotyping and immunoprecipitation methods
• Development, purification and characterization of antibodies
• Detection of cytokines, chemokines, antibodies and other biomarkers with the xMAP technology on the Luminex 

These are only a few examples of what we can do. For more information, or a special request, please contact us toll free at 1-866-688-2474 or by e-mail at businessdevelopment@cirion.com.

< back